EE200300247A - Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena - Google Patents

Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena

Info

Publication number
EE200300247A
EE200300247A EEP200300247A EEP200300247A EE200300247A EE 200300247 A EE200300247 A EE 200300247A EE P200300247 A EEP200300247 A EE P200300247A EE P200300247 A EEP200300247 A EE P200300247A EE 200300247 A EE200300247 A EE 200300247A
Authority
EE
Estonia
Prior art keywords
isothiazole
antiproliferative agents
carboxamide salts
carboxamide
salts
Prior art date
Application number
EEP200300247A
Other languages
English (en)
Estonian (et)
Inventor
G. Gant Thomas
Robert Williams Glenn
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of EE200300247A publication Critical patent/EE200300247A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
EEP200300247A 2000-11-28 2001-11-19 Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena EE200300247A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25351300P 2000-11-28 2000-11-28
PCT/IB2001/002193 WO2002044158A1 (fr) 2000-11-28 2001-11-19 Sels d'un isothiazole-4-carboxamide et leur utilisation comme agents anti-hyperproliferatifs

Publications (1)

Publication Number Publication Date
EE200300247A true EE200300247A (et) 2003-10-15

Family

ID=22960587

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300247A EE200300247A (et) 2000-11-28 2001-11-19 Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena

Country Status (50)

Country Link
US (1) US6831091B2 (fr)
EP (1) EP1337521B1 (fr)
JP (2) JP2004514714A (fr)
KR (2) KR20050116401A (fr)
CN (1) CN1231474C (fr)
AP (1) AP2001002358A0 (fr)
AR (1) AR031512A1 (fr)
AT (1) ATE340786T1 (fr)
AU (2) AU1420402A (fr)
BG (1) BG107752A (fr)
BR (1) BR0115621A (fr)
CA (1) CA2430065C (fr)
CR (1) CR6963A (fr)
CY (1) CY1106240T1 (fr)
CZ (1) CZ20031315A3 (fr)
DE (1) DE60123461T2 (fr)
DK (1) DK1337521T3 (fr)
DO (1) DOP2001000288A (fr)
EA (1) EA005859B1 (fr)
EC (1) ECSP034628A (fr)
EE (1) EE200300247A (fr)
ES (1) ES2271086T3 (fr)
GE (1) GEP20053652B (fr)
GT (1) GT200100237A (fr)
HK (1) HK1059085A1 (fr)
HN (1) HN2001000268A (fr)
HR (1) HRP20030408A2 (fr)
HU (1) HUP0302553A3 (fr)
IL (1) IL155371A0 (fr)
IS (1) IS6788A (fr)
MA (1) MA26960A1 (fr)
MX (1) MXPA03004714A (fr)
MY (1) MY136686A (fr)
NO (1) NO325187B1 (fr)
NZ (1) NZ525788A (fr)
OA (1) OA12532A (fr)
PA (1) PA8533801A1 (fr)
PE (1) PE20020591A1 (fr)
PL (1) PL362079A1 (fr)
PT (1) PT1337521E (fr)
SI (1) SI1337521T1 (fr)
SK (1) SK5862003A3 (fr)
SV (1) SV2002000748A (fr)
TN (1) TNSN01167A1 (fr)
TW (1) TWI287542B (fr)
UA (1) UA74221C2 (fr)
UY (1) UY27039A1 (fr)
WO (1) WO2002044158A1 (fr)
YU (1) YU36403A (fr)
ZA (1) ZA200303341B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA60365C2 (uk) * 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
JP2002534468A (ja) 1999-01-13 2002-10-15 バイエル コーポレイション p38キナーゼ阻害剤としてのω−カルボキシアリール置換ジフェニル尿素
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
WO2003068229A1 (fr) 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation N-oxydes de pyridine, de quinoline, et d'isoquinoline en tant qu'inhibiteurs de kinase
EP2324825A1 (fr) 2002-02-11 2011-05-25 Bayer Healthcare LLC Arylurées dotées d'une activité d'inhibition de l'angiogenèse
BR0312798A (pt) * 2002-07-25 2005-05-03 Pfizer Prod Inc Derivados de isotiazol úteis como agentes anticancerìgenos
AP2005003232A0 (en) * 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
ATE366108T1 (de) 2003-05-20 2007-07-15 Bayer Pharmaceuticals Corp Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten
NZ580384A (en) 2003-07-23 2011-03-31 Bayer Pharmaceuticals Corp 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
RU2317295C1 (ru) * 2003-10-27 2008-02-20 Мерк Энд Ко., Инк. Соль антагониста ccr-2
EP1694686A1 (fr) 2003-12-19 2006-08-30 Takeda San Diego, Inc. Inhibiteurs de kinase
WO2005102327A1 (fr) * 2004-04-20 2005-11-03 Pfizer Products Inc. Formes posologiques et procedes de traitement utilisant des inhibiteurs vegfr
JP2007535565A (ja) 2004-04-30 2007-12-06 バイエル ファーマシューティカルス コーポレーション 癌の治療に有用な置換ピラゾリル尿素誘導体
TW200538104A (en) * 2004-05-17 2005-12-01 Pfizer Prod Inc Phenyl derivatives for the treatment of abnormal cell growth
EP1778669A2 (fr) 2004-08-18 2007-05-02 Takeda San Diego, Inc. Inhibiteurs de kinase
WO2006044687A2 (fr) 2004-10-15 2006-04-27 Takeda San Diego, Inc. Inhibiteurs de kinase
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
SI2044043T2 (sl) 2006-06-16 2021-04-30 H. Lundbeck A/S 1-2(-2,4-dimetilfenilsulfanil)-fenil)piperazin hidrobromid kot spojina s kombinirano aktivnostjo ponovnega privzema serotonina, 5-ht3 in 5-ht1a za zdravljenje kognitivne motnje
US7932390B2 (en) 2006-06-29 2011-04-26 Hoffman-La Roche Inc. Substituted thieno[3,2-C]pyridine carboxylic acid derivatives
BRPI0719883A2 (pt) 2006-10-09 2015-05-05 Takeda Pharmaceutical Inibidores de quinase
MX2010001636A (es) 2007-08-14 2010-03-15 Hoffmann La Roche Derivados de pirazolo[3,4-d]-pirimidina como agentes antiproliferativos.
WO2011073521A1 (fr) 2009-12-15 2011-06-23 Petri Salven Méthodes pour l'enrichissement de cellules progénitrices endothéliales adultes et leurs utilisations
CA2806921C (fr) 2010-07-23 2019-11-26 Trustees Of Boston University Inhibiteurs anti-despr comme agents therapeutiques pour l'inhibition de l'angiogenese pathologique et de l'invasivite des cellules tumorales et pour l'imagerie moleculaire et l'administration ciblee
EP2968650B1 (fr) * 2013-03-14 2019-01-16 PanOptica, Inc. Formulations oculaires destinées à l'administration de médicament au segment postérieur de l'oeil
EP3193867B1 (fr) * 2014-09-17 2021-01-20 PanOptica, Inc. Formulations oculaires permettant l'administration de médicament et la protection du segment antérieur de l'oeil

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA60365C2 (uk) * 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця

Also Published As

Publication number Publication date
PA8533801A1 (es) 2002-10-31
HRP20030408A2 (en) 2003-08-31
GEP20053652B (en) 2005-11-10
DK1337521T3 (da) 2007-01-29
PE20020591A1 (es) 2002-07-06
DOP2001000288A (es) 2002-12-15
NO20032388L (no) 2003-07-18
IL155371A0 (en) 2003-11-23
WO2002044158A1 (fr) 2002-06-06
MXPA03004714A (es) 2003-08-19
HUP0302553A3 (en) 2009-03-30
CY1106240T1 (el) 2011-06-08
AU1420402A (en) 2002-06-11
BR0115621A (pt) 2003-09-02
NZ525788A (en) 2004-11-26
YU36403A (sh) 2006-08-17
EA005859B1 (ru) 2005-06-30
ECSP034628A (es) 2003-07-25
SV2002000748A (es) 2002-12-02
KR20050116401A (ko) 2005-12-12
PT1337521E (pt) 2006-12-29
JP2008056692A (ja) 2008-03-13
NO20032388D0 (no) 2003-05-27
JP4971946B2 (ja) 2012-07-11
MY136686A (en) 2008-11-28
KR20030059275A (ko) 2003-07-07
HK1059085A1 (en) 2004-06-18
MA26960A1 (fr) 2004-12-20
TWI287542B (en) 2007-10-01
GT200100237A (es) 2002-07-03
DE60123461T2 (de) 2007-02-15
CA2430065C (fr) 2008-05-20
SI1337521T1 (sl) 2006-12-31
CR6963A (es) 2003-11-25
HN2001000268A (es) 2002-01-30
CZ20031315A3 (cs) 2004-04-14
CN1231474C (zh) 2005-12-14
NO325187B1 (no) 2008-02-11
EP1337521A1 (fr) 2003-08-27
TNSN01167A1 (fr) 2005-11-10
CN1476439A (zh) 2004-02-18
SK5862003A3 (en) 2004-05-04
IS6788A (is) 2003-04-14
AR031512A1 (es) 2003-09-24
OA12532A (en) 2006-06-02
UY27039A1 (es) 2002-07-31
HUP0302553A2 (hu) 2003-11-28
AU2002214204B2 (en) 2007-05-24
JP2004514714A (ja) 2004-05-20
CA2430065A1 (fr) 2002-06-06
EA200300424A1 (ru) 2003-10-30
UA74221C2 (uk) 2005-11-15
PL362079A1 (en) 2004-10-18
US6831091B2 (en) 2004-12-14
ZA200303341B (en) 2004-04-30
ES2271086T3 (es) 2007-04-16
EP1337521B1 (fr) 2006-09-27
ATE340786T1 (de) 2006-10-15
AP2001002358A0 (en) 2001-12-31
US20020151573A1 (en) 2002-10-17
DE60123461D1 (de) 2006-11-09
BG107752A (bg) 2004-01-30

Similar Documents

Publication Publication Date Title
EE200300247A (et) Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena
EE05350B1 (et) Antiproliferatiivsete vahenditena kasutatavad bensoimidasooli derivaadid
EE200200341A (et) Asendatud oksasolidinoonid ja nende kasutamine
DE60137897D1 (de) Absorbierender Artikel
DE60112221D1 (de) Absorbierender Artikel
DE60140977D1 (de) Absorbierender artikel
DE60104745D1 (de) Absorbierender Artikel
DE60139744D1 (de) Absorbierender artikel
DE60114289D1 (de) Absorbierender Artikel
DE60108385D1 (de) Absorbierender artikel
EE200200550A (et) Karbamaatsed kaspaasi inhibiitorid ja nende kasutamine
DE60142945D1 (de) Absorbierender Artikel
EE200200626A (et) Antraniilamiidid ja nende kasutamine ravimitena
DE60117928D1 (de) Saugfähiger Artikel
ATE267178T1 (de) Diazepinderivate oder deren salze
DE60139432D1 (de) Absorbierender Artikel
DE60139642D1 (de) Absorbierender artikel
DE60135287D1 (de) Saugfähiger Einwegartikel und Schutzmittel
DE60141727D1 (de) Absorbierender artikel
DE60137738D1 (de) Absorbierender Artikel
NO20025510L (no) Dibenzoazulen-derivater samt anvendelse derav
DE60111909D1 (de) Absorbierender Artikel
FI20001715A0 (fi) Rankoihin liittyvät järjestelyt ja menetelmät
DE50104507D1 (de) Reinigungs- und desinfektionsmittel
FI20000818A0 (fi) Dermatologinen käyttö ja valmiste